NCT03701646View on ClinicalTrials.gov

ClearSight Validation in Pediatrics

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

June 1, 2019

Conditions
ShockHypotension and Shock
Interventions
DEVICE

Measurement by Clearsight device

Clearsight Device is used to obtain non-invasive measurements to be correlated to standard invasive measurements.

Trial Locations (1)

19805

Nemours A.I. duPont Hospital for Children, Wilmington

All Listed Sponsors
lead

Nemours Children's Clinic

OTHER

NCT03701646 - ClearSight Validation in Pediatrics | Biotech Hunter | Biotech Hunter